Lavaca Capital LLC Eli Lilly & CO Put Options Transaction History

Lavaca Capital LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $418,095 - $490,905	-1,500 Reduced 30.61%	3,400 $1.1 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $46,938 - $58,332	200 Added 4.26%	4,900 $1.4 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $44,970 - $55,808	-200 Reduced 4.08%	4,700 $1.3 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $66,480 - $81,813	-300 Reduced 5.77%	4,900 $1.13 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $938,860 - $1.21 Million	5,200 New	5,200 $1.19 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Lavaca Capital LLC with notifications on news.